MedTrace Logo

"Cryptogenic Stroke and Atrial Fibrillation Detection Through Implantable Loop Recorder (ILR)"

NCT01025947 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2010-06-28

No results posted yet for this study

Summary

STUDY TYPE:

Prospective, national , multicenter, and observational study.

OBJECTIVE:

To assess the incidence of AF in patients with cryptogenic stroke who have implanted an AF detection device during a period of 2 years.

DEVICE:

Reveal XT 9529 (SQDM)

SAMPLE SIZE AND STUDY DURATION:

100 patients enrolled which will be followed during a period of 2 years.

Conditions

Sponsors & Collaborators

  • Hospital Universitario Virgen de la Arrixaca

    collaborator OTHER

  • Universidad de Murcia

    collaborator OTHER

  • University of Valencia

    lead OTHER

Principal Investigators

  • Ricardo Ruiz-Granell, MD, Phd · Hospital Clinico Universitario de Valencia

  • Arcadio Garcia-Alberola, MD, PhD · Hospital Universitario Virgen de la Arrixaca

  • Ana Morales, MD · Hospital Universitario Virgen de la Arrixaca

  • Alejandro Ponz, MD · Hospital Clinico Universitario de Valencia

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01025947 on ClinicalTrials.gov